Clinical Trial Update: 75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2) [Phase 4]

View source ↗

Summary

Phase 4 ISAR-CHOICE-2 evaluates 75 mg versus 150 mg clopidogrel maintenance dosing after percutaneous coronary intervention in patients with coronary artery dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Disease | Phase 4 | Status: COMPLETED